 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| Vaccine developer iBio seeks more than $200 million from former Newark partner Fraunhofer The company's stock price spiked on speculation that its vaccines could be used in the fight against the Ebola pandemic. The stock price later ...
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar